Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt No Debt
APDN's Cash-to-Debt is ranked higher than
99% of the 260 Companies
in the Global Security & Protection Services industry.

( Industry Median: 0.69 vs. APDN: No Debt )
Ranked among companies with meaningful Cash-to-Debt only.
APDN' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 7 Max: No Debt
Current: No Debt
Equity-to-Asset 0.73
APDN's Equity-to-Asset is ranked higher than
82% of the 261 Companies
in the Global Security & Protection Services industry.

( Industry Median: 0.48 vs. APDN: 0.73 )
Ranked among companies with meaningful Equity-to-Asset only.
APDN' s Equity-to-Asset Range Over the Past 10 Years
Min: -8.04  Med: -0.24 Max: 0.89
Current: 0.73
-8.04
0.89
Interest Coverage No Debt
APDN's Interest Coverage is ranked higher than
99% of the 214 Companies
in the Global Security & Protection Services industry.

( Industry Median: 15.81 vs. APDN: No Debt )
Ranked among companies with meaningful Interest Coverage only.
APDN' s Interest Coverage Range Over the Past 10 Years
Min: No Debt  Med: No Debt Max: No Debt
Current: No Debt
Piotroski F-Score: 3
Altman Z-Score: -15.04
Beneish M-Score: -2.09
WACC vs ROIC
-9.97%
-242.17%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating Margin % -351.45
APDN's Operating Margin % is ranked lower than
98% of the 265 Companies
in the Global Security & Protection Services industry.

( Industry Median: 6.22 vs. APDN: -351.45 )
Ranked among companies with meaningful Operating Margin % only.
APDN' s Operating Margin % Range Over the Past 10 Years
Min: -10279.51  Med: -487.93 Max: -87.19
Current: -351.45
-10279.51
-87.19
Net Margin % -350.89
APDN's Net Margin % is ranked lower than
98% of the 265 Companies
in the Global Security & Protection Services industry.

( Industry Median: 3.44 vs. APDN: -350.89 )
Ranked among companies with meaningful Net Margin % only.
APDN' s Net Margin % Range Over the Past 10 Years
Min: -10905.74  Med: -629.75 Max: 1337.29
Current: -350.89
-10905.74
1337.29
ROE % -97.49
APDN's ROE % is ranked lower than
97% of the 260 Companies
in the Global Security & Protection Services industry.

( Industry Median: 7.06 vs. APDN: -97.49 )
Ranked among companies with meaningful ROE % only.
APDN' s ROE % Range Over the Past 10 Years
Min: -830.18  Med: -436.21 Max: -97.49
Current: -97.49
-830.18
-97.49
ROA % -77.03
APDN's ROA % is ranked lower than
98% of the 267 Companies
in the Global Security & Protection Services industry.

( Industry Median: 2.38 vs. APDN: -77.03 )
Ranked among companies with meaningful ROA % only.
APDN' s ROA % Range Over the Past 10 Years
Min: -541.78  Med: -307.08 Max: 235.24
Current: -77.03
-541.78
235.24
ROC (Joel Greenblatt) % -423.99
APDN's ROC (Joel Greenblatt) % is ranked lower than
97% of the 265 Companies
in the Global Security & Protection Services industry.

( Industry Median: 9.90 vs. APDN: -423.99 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
APDN' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -88962.5  Med: -3291.28 Max: 13494.74
Current: -423.99
-88962.5
13494.74
3-Year Revenue Growth Rate 0.60
APDN's 3-Year Revenue Growth Rate is ranked lower than
61% of the 206 Companies
in the Global Security & Protection Services industry.

( Industry Median: 3.80 vs. APDN: 0.60 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
APDN' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: -8.7 Max: 111.8
Current: 0.6
0
111.8
3-Year EBITDA Growth Rate -16.80
APDN's 3-Year EBITDA Growth Rate is ranked lower than
85% of the 177 Companies
in the Global Security & Protection Services industry.

( Industry Median: 5.30 vs. APDN: -16.80 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
APDN' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: -42.45 Max: 1.6
Current: -16.8
0
1.6
3-Year EPS without NRI Growth Rate -30.40
APDN's 3-Year EPS without NRI Growth Rate is ranked lower than
89% of the 154 Companies
in the Global Security & Protection Services industry.

( Industry Median: 6.60 vs. APDN: -30.40 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
APDN' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: -24.5 Max: 353.1
Current: -30.4
0
353.1
GuruFocus has detected 7 Warning Signs with Applied DNA Sciences Inc $APDN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» APDN's 10-Y Financials

Financials (Next Earnings Date: 2017-05-09 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with APDN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Consulting & Outsourcing » Security & Protection Services    NAICS: 561621    SIC: 7382
Compare:OTCPK:RSKIA, OTCPK:NTSFF, OTCPK:IDWAF, AMEX:MOC, OTCPK:INDVF, NAS:DGLY, OTCPK:MACE, OTCPK:ALXXF, OTCPK:WSMTF, OTCPK:SMME, NAS:NXTD, OTCPK:BKYI, OTCPK:GKPRF, AMEX:UUU, OTCBB:BFDI, OTCPK:BLPG, AMEX:VII, OTCPK:VRME, OTCPK:BSMZF, NAS:MAGS » details
Traded in other countries:UDJN.Germany,
Headquarter Location:USA
Applied DNA Sciences Inc is a provider of botanical DNA-based security and authentication solutions which protects products, intellectual property of companies, counterfeiting, fraud and diversion.

Applied DNA Sciences Inc is a Delaware Corporation formed in 1983 Datalink Systems, Inc. In 1998, the Company reincorporated in Nevada, and in 2002, it changed its name to its current name, Applied DNA Sciences, Inc. In December 2008, it completed its reincorporation from Nevada to the State of Delaware. The Company is a provider of botanical-DNA based security and authentication solutions that can help protect products, brands and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature DNA is a platform ingredient, at the core of all the Company's security solutions. SigNature DNA is based on full, double stranded plant DNA, and provides forensic power and protection for a wide array of applications. SigNature DNA markers are an ingredient that can be used to fortify brand protection efforts; mark, track and convict criminals; and strengthen supply chain security. Custom DNA sequences can be embedded into a wide range of host carriers including ink, varnish, thread, laminates and metal coatings. SigNature T botanical DNA markers are used for brand protection efforts and raw material source compliance programs. This fiberTyping process provides DNA verification to help manufacturers, retailers and brand owners ensure quality, safety and compliance of their products. DNANet, a botanical DNA marker can be used to definitively link evidence and offenders to specific crime scenes. Whether deployed as a residential asset marker, an offender spray in a retail location or a degradation dye in cash handling boxes, DNA markers facilitate conviction, and establish a heightened level of deterrence. digitalDNA is a new security tool that utilizes the flexibility of mobile communications, the instant accessibility of secure, cloud-based data, and the absolute certainty of DNA to make item tracking and authentication fast, easy and definitive, while providing the opportunity to create a new customer interface. digitalDNA is a DNA-secured form of the QR code. The product uses forensic authentication of a botanical DNA marker, sequence-encrypted within a secure QR code, and physically included within the ink used to digitally print the code. The Company has 41 patents,83 patent applications, 37 registered trademarks and 8 trademark applications.The Company competes with existing suppliers and new competitors and continues to enter the market. Some of its competitors that operate in the anti-counterfeiting and fraud prevention markets include: American Bank Note Holographics, Inc., Applied Optical Technologies, Authentix, ChromoLogic LLC, Collectors Universe Inc., Collotype, Data Dot Technology, De La Rue Plc., Digimarc Corp., DNA Technologies, Inc., ID Global, Informium AG, Inksure Technologies, , L-1 Identity Solutions, Media Sec Technologies, Nanotech Security Corp, Nokomis, Inc. opSec Security Group plc., SmartWater Technology, Inc., Sun Chemical Corp, Tracetag, Prooftag SAS and

Top Ranked Articles about Applied DNA Sciences Inc

Applied DNA Sciences Partners With Palmetto Synthetics and Techmer PM, Entering Synthetic Fibers for First Time, Expanding in Athletic Apparel and Automotive Textile Markets

SigNature T DNA-Tagging Synthetic Fibers Open New, Larger Market in Textiles
STONY BROOK, NY--(Marketwired - June 07, 2016) - Applied DNA Sciences (ADNAS), Inc. (NASDAQ: APDN), a provider of DNA-based supply chain, anti-counterfeiting, genotyping and anti-theft technology, and authentication technologies, has partnered with Palmetto Synthetics, a leader in the production of high quality, specialty synthetic fiber and Techmer PM, a leading materials design company, to launch its SigNature® T DNA system in synthetic fibers, and expand its presence in the athletic apparel industry and the automotive textile category.Palmetto Synthetics fiber has many uses, but is best known in the apparel, automotive and industrial applications. Fibers are used in trunk liners and throughout the interior of cars in the visible surface materials. In addition, the fiber manufactured by Palmetto is also used in other polyester and nylon fabrics such as footwear, performance apparel, geotextiles fabrics for erosion control, roofing products and filtration media. Palmetto Synthetics fiber types include, but are not limited to: PET; PETG; PBT; PA6, 6; PLA; as well as a line of post consumer recycled fibers. Palmetto Synthetics also employs a wealth of additive and finish technology along with a wide range of cross-section availability for fiber customization."We have an eye to the future, and it has arrived with SigNature T DNA technology," said David Poston, President of Palmetto Synthetics. "This sets a new industry standard in assuring quality and purity at the source. SigNature T DNA ensures traceability and transparency at every stage of the supply chain, with performance and strength delivered consistently. We are honored to be working with ADNAS and Techmer, and excited about the many benefits this partnership will bring to consumers and manufacturers."Recently, in Clinton, Tennessee, unique SigNature T DNA molecular tags were attached to Techmer PM polyester formulations and supplied to Palmetto, who used them to manufacture polyester fiber. The Techmer PM formulation is a component of a system of solutions for fiber that includes colors and additives. These fibers were converted into synthetic fabrics for commercial and industrial applications. The initial stage tagged five million lbs. of PET fiber. The process will be scaled up to many millions of lbs. over the next year.SigNature T DNA solution now tags natural and synthetic fibers at industrial scale, and maintains a secure chain of custody as the product moves from source (pellets in the case of synthetics) to fiber to product to consumer."We are proud to partner with Applied DNA Sciences and Palmetto to commercialize DNA marking and authentication within fiber applications," said John Manuck, Founder and CEO, Techmer PM. "As a leader in materials design, we are constantly looking for opportunities to create innovations which benefit our customers and OEMs, and this partnership underscores that commitment."Techmer PM is a leading materials designer and works in partnership with plastics processors, OEMs, and designers to solve some of their most difficult business, manufacturing, and sustainability challenges. Techmer PM's solutions modify the aesthetics as well as extend and maintain the physical properties of plastic and fiber products. In partnership with Applied DNA Sciences, Techmer PM can now integrate Signature T DNA into solutions for its customers to ensure integrity of the entire supply chain."We have been a change agent for the cotton fiber market, by bringing certainty to a complex supply chain. With our entry into synthetic fibers, Applied DNA Sciences is entering a market that is more than three-times larger than cotton, and is the basis of 60% of the global textile industry," said Dr. James Hayward, President and CEO of ADNAS. "In just one DNA tagging campaign, companies can safeguard against product recalls and liability, and elevate their business, based on high integrity, quality, and sustainability to ensure the smallest possible environmental footprint."About Applied DNA SciencesWe make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. Our patented DNA-based solutions can be used to identify, tag, track, and trace products, to help assure authenticity, traceability and quality of products. SigNature® DNA describes the platform ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. We are also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.Go to adnas.com for more information, events and to learn more about how Applied DNA Sciences makes life real and safe. Common stock listed on NASDAQ under the symbol APDN, and warrants are listed under the symbol APDNW.Forward-Looking StatementsThe statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 14, 2015, and our subsequent quarterly report on Form 10-Q filed on February 10, 2016 which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.
Investor contact:
Debbie Bailey
631-240-8817
Email contact

media contact:
Kristen Bujold
781-639-4924
Email contact

program contact:
MeiLin Wan
631-240-8849
Email contact

web: www.adnas.com
twitter: @APDN



Read more...
Applied DNA Sciences Appoints Dr. Barbara Brockway as Director of Personal Care

Personal Care Expert and Innovator to Lead Expansion Into Cosmetics, Fragrances, and Personal Care
STONY BROOK, NY--(Marketwired - June 06, 2016) - Applied DNA Sciences (ADNAS), Inc. (NASDAQ: APDN), a provider of DNA-based supply chain, anti-counterfeiting, genotyping and anti-theft technology, and authentication technologies, announced today the appointment of Dr. Barbara Brockway as Director of Personal Care. Dr. Brockway is an innovator and leader in the world of cosmetics formulation, food science, branding, and supply chain management in the personal care industry.Dr. Brockway is a sought after speaker in personal care, lecturing on topics such as biochemistry, rheology, cereal science, food science, and the latest technology in cosmetics. A well-respected author of published scientific papers and chapters in technical books and trade journals, Dr. Brockway is often called upon by companies and organizations for collaborative projects on reimagining the future of personal care as consumers become more conscious about sustainability and proof of origin.Dr. Brockway's experience includes being Scientific Advisor at IMCD, Laboratory Manager at Huntsman LLC, Director of R&D/Marketing at The Collaborative Group, Ltd, and Head of Applied Research at The Body Shop International. While at The Body Shop, Dr. Brockway was recognized with the "Walk the Talk" award for being a passionate advocate of the company's ethics and culture. Dr. Brockway also holds or held a number of high-level positions in the personal care industry including being the Past President of the Society of Cosmetic Scientists, a Trustee on The Body Shop Foundation and a Governor of Chichester University. Dr. Brockway holds a Ph.D. in Biochemistry and a B.Sc. with honors from the University of Kent. "We are delighted to have Dr. Brockway join Applied DNA Sciences at a time where there is significant need for consumers to better understand the origin of the personal care products they buy. Through the development of partnerships with personal care companies, Dr. Brockway is poised to bring greater confidence to consumers and companies alike," said Dr. James Hayward, CEO and president of Applied DNA Sciences, Inc. He continued: "The integration of personal care complements our expansion into pharmaceutics, markets that are regulated by the FDA, in which authenticity and supply chain transparency are essential."About Applied DNA SciencesWe make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. Our patented DNA-based solutions can be used to identify, tag, track, and trace products, to help assure authenticity, traceability and quality of products. SigNature® DNA describes the platform ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. We are also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.Go to adnas.com for more information, events and to learn more about how Applied DNA Sciences makes life real and safe. Common stock listed on NASDAQ under the symbol APDN, and warrants are listed under the symbol APDNW. Forward-Looking StatementsThe statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 14, 2015, and our subsequent quarterly reports on Form 10-Q filed on February 10, 2016 and May 12, 2016 which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.
Investor contact:
Debbie Bailey
631-240-8817
[email protected]

Media contact:
Susan Forman
Dian Griesel Int'l.
212-825-3210
[email protected]

web: www.adnas.com
twitter: @APDN



Read more...
Applied DNA Sciences Partners With CGPR

To Lead Its Textile and Apparel Public Relations Program
STONY BROOK, NY--(Marketwired - May 25, 2016) -  Applied DNA Sciences (ADNAS), Inc. (NASDAQ: APDN), a provider of DNA-based supply chain, anti-counterfeiting, anti-theft technology products, genotyping and product authentication solutions, today named CGPR as their public relations agency of record for their textile and apparel business. CGPR will provide strategic counsel to continue to drive awareness of its exciting textile and apparel DNA marking, validation and authentication platform. Major brands and supply chain partners are using the platform to ensure integrity of products and associated claims. The PR plan will complement the demand creation plan in place and support the launch of new technologies, solutions and products."CGPR has robust component experience with iconic global brands including Microban, PrimaLoft and W.L. Gore & Associates," said John Shearman, executive director of marketing. "Their expertise will help raise the visibility of ADNAS' proprietary technologies and educate manufacturers, retailers and consumers to the benefits of their platform. CGPR will keep our technologies top of mind with key decision makers in the home textile and apparel communities, target growth categories for the coming year. We look forward to a long-term partnership." About CGPR: CGPR is a public relations firm with a consumer focus, leveraging a wide scope of expertise on behalf of clients that are established leaders in their industries. This enables the agency to utilize its years of experience across a wide variety of categories, including corporate communications, social media, government relations, crisis management, media relations and strategic planning. The agency, founded more than 23 years ago by Chris Ann Goddard, has a staff with a proven track record from both the agency and client perspectives. CGPR is headquartered in Marblehead, Mass., just outside of Boston. For more information, visit: www.cgprpublicrelations.com. About Applied DNA Sciences
We make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. Our patented DNA-based solutions can be used to identify, tag, track, and trace products, to help assure authenticity, traceability and quality of products. SigNature® DNA describes the platform ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. We are also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.Go to adnas.com for more information, events and to learn more about how Applied DNA Sciences makes life real and safe. Common stock listed on NASDAQ under the symbol APDN, and warrants are listed under the symbol APDNW.  Forward-Looking Statements
The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 14, 2015,and our subsequent quarterly reports on Form 10-Q filed on February 10, 2016 and May 12, 2016 which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.
Investor contact:
Debbie Bailey
631-240-8817
Email contact

media contact:
Kristen Bujold
781-639-4924
Email contact

program contact:
John Shearman
631-240-8838
Email contact

web: www.adnas.com
twitter: @APDN



Read more...
Applied DNA Sciences to Present at Upcoming Mauldin Economics Strategic Investment Conference
STONY BROOK, NY--(Marketwired - May 24, 2016) -
 Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA), a provider of DNA-based supply chain, anti-counterfeiting and anti-theft technology, product genotyping and product authentication solutions, announced that management is scheduled to participate at the Mauldin Economics Strategic Investment Conference in Dallas, Texas, May 24 through May 27, 2016. The theme of this conference is 'Decade of Disruption: Investing in a Transformed World' and it is expected that over 700 investors will be in attendance.One of only three companies invited to participate at the conference, Applied DNA's President and Chief Executive Officer, Dr. James Hayward, will participate in a panel discussion on the most important breakthroughs in biotechnology on Wednesday, May 25 and Thursday, May 26. Applied DNA will also be an exhibitor at this conference which attracts high net worth individuals and financial professionals from around the world. "Residing at the intersection of technology, market opportunity and the ability to transform our daily lives, the Strategic Investment Conference enables us to expand the awareness of Applied DNA with investors who invest in tomorrow's disruptive technologies today," stated Dr. Hayward. "Applied DNA's contribution has been to redefine "TRUST" using the biology of authenticity. The global societal and economic future relies on clear definitions of identity ("Trust me, this drug is the real thing"), origin ("Trust me, this is Italian"), claims ("Trust me, this was organically grown"), composition ("Trust me, this is 100% Pima cotton"), and ethical sourcing ("Trust me, no child labor helped to produce this product"). The Applied DNA solution is already being deployed in textiles and apparel through DNA marking of 100 million pounds of cotton. Over 500,000 critical microchips have been DNA marked, protecting our war fighters around the world. We also are securing ATMs in Europe and protecting over 1 million personal assets globally.Our convergence of biotech and information technologies enable DNA-based security solutions to answer the formidable macroeconomic and geopolitical challenges of our day and of tomorrow. Judy Murrah, our Chief Information Officer, and I look forward to presenting Applied DNA to the attendees of this prestigious conference." If you would like to schedule a one-on-one meeting with the Company's management team at the conference, please email Debbie Bailey, Investor Relations Officer, on [email protected]. For more information about the Mauldin Economics Strategic Investment Conference, please visit mauldineconomics.com/sic-2016.  About Applied DNA Sciences
We make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. Our patented DNA-based solutions can be used to identify, tag, track, and trace products, to help assure authenticity, traceability and quality of products. SigNature® DNA describes the platform ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. We are also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.Go to adnas.comfor more information, events and to learn more about how Applied DNA Sciences makes life real and safe. Common stock listed on NASDAQ under the symbol APDN, and warrants are listed under the symbol APDNW.  Forward-Looking Statements
The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 14, 2015,and our subsequent quarterly reports on Form 10-Q filed on February 10, 2016 and May 12, 2016 which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.
Investor contact:
Debbie Bailey
631-240-8817 
[email protected]

Media contact:
Susan Forman
Dian Griesel Int'l.
212-825-3210
[email protected]

web: www.adnas.com
twitter: @APDN



Read more...
Applied DNA Sciences Signs Five-Year, $2.5 Million Blanket Purchase Agreement With Federal Agency

Allows DNA-Based Security Solutions to Be Quickly Ordered and Delivered
STONY BROOK, NY--(Marketwired - May 10, 2016) - Applied DNA Sciences (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based supply-chain, anti-counterfeiting and anti-theft technology, product genotyping and product authentication solutions,announced today that it has signed a new $2.5 million contract with a U.S. government agency for use of its SigNature® DNA products. The contract vehicle is a blanket purchase agreement (BPA) with a period of performance of April 1, 2016 through March 31, 2021. The contract allows for the sale of both standard products and the development of new products over the five-year term. The BPA is a simplified acquisition method that government agencies use to fill anticipated repetitive needs for supplies and/or services. Essentially, BPAs are like "charge accounts" set-up with trusted suppliers that have demonstrated dependable past performance and have a history of quality services and supplies. The BPA is an efficient contract vehicle because once established, repeat purchases are easy for both sides.The contract vehicle also allows Applied DNA Sciences the ability to develop new products and solutions for the contracting agency at an accelerated deployment pace compared with traditional contract-development paths. Rapid adoption of "bleeding edge" DNA-tracing technologies can provide the US government with a robust Safeguards response to manage the risks associated with the supply chain for Mission Critical infrastructure components."Our performance record at the federal level speaks for itself and is one of our best selling tools," said Dr. James Hayward, Chairman, President and CEO of APDN. "As our reputation spreads within and across agencies, as engaged creative solution providers and partners, we gain new federal customers. This BPA will allow rapid deployment with new applications without the need to negotiate individual contracts. We are thrilled to continue to be of service to our government." About Applied DNA Sciences
We make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. Our patented DNA-based solutions can be used to identify, tag, track, and trace products, to help assure authenticity, traceability and quality of products. SigNature® DNA describes the platform ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. We are also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.Go to adnas.com for more information, events and to learn more about how Applied DNA Sciences makes life real and safe. Common stock listed on NASDAQ under the symbol APDN, and warrants are listed under the symbol APDNW. Forward Looking Statements
The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 14, 2015, and our subsequent quarterly report on Form 10-Q filed on February 10, 2016 which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.
Investor contacts:

Debbie Bailey
631-240-8817
[email protected]

Sanjay M. Hurry
212-838-3777
[email protected]

Media contact:
Susan Forman
Dian Griesel Int'l.
212-825-3210
[email protected]

web:www.adnas.com
twitter: @APDN



Read more...
Applied DNA Sciences Appoints Bob Miglani as Chief of Business Development

Former Pfizer Executive to Lead Expansion Into Pharmaceuticals
STONY BROOK, NY--(Marketwired - May 05, 2016) - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based supply chain, anti-counterfeiting and anti-theft technology, product genotyping and product authentication solutions, has appointed Bob Miglani as Chief of Business Development. In his new full-time role, Mr. Miglani will be responsible for building the Company's business within the FDA-regulated markets, including pharmaceuticals, foods, personal care and medical devices. He will also lead the team responsible for creating and driving commercial strategies within these large and important sectors.Mr. Miglani brings 23 years of deep industry experience from Pfizer Inc., where he served in a series of roles of increasing responsibility, most recently as Senior Director, External Medical Affairs. In that role, he led Pfizer's efforts to partner with external medical, scientific and consumer organizations. Over the course of his career, Mr. Miglani has held diverse global positions encompassing sales, marketing research, strategy, pricing & reimbursement, public affairs and policy, market access, patient advocacy, communications and partnership development.Mr. Miglani has a proven track record of developing innovative partnerships with medical and healthcare organizations in the United States, Europe, India and other parts of the world. In addition to being a Washington Post bestselling author of the book Embrace the Chaos, he is a thought leader on thriving in change and a passionate advocate for embracing disruptive technologies to help society. He earned an MBA from Pace University, a Bachelor of Science degree from Rider University and participated in Executive Leadership Programs at INSEAD and Harvard University.Mr. Miglani was previously appointed to Applied DNA Sciences' Strategic Advisory Board in March 2016; he will step down from that position to become a full-time member of the Applied DNA Sciences management team."Having seen firsthand the capabilities and technology that Applied DNA Sciences offers, I realized that there is a significant opportunity for this solution in the marketplace. We're working in a complex global system where patients are increasingly at greater risk of getting a counterfeit medicine. I believe that Applied DNA Sciences technology offers a unique solution to help track and trace medicines globally, fight counterfeits and provide undisputed proof of origin, helping consumers feel safe and confident and companies feel secure in protecting their brands," Mr. Miglani said. "I look forward to working with my colleagues on the management team to build our business in the pharmaceutical sector and establish meaningful partnerships with partners around the world.""We are delighted to have Bob join our leadership team as his knowledge, expertise and insight will be an important asset to us as we expand our pharmaceutical solutions," said Dr. James Hayward, President and CEO of Applied DNA Sciences. "One particular area of focus will be to help companies implement new regulations such as the European Union's mandate requiring safety features for medicine packaging to combat counterfeiting of pharmaceuticals. In order to address the increasingly serious issue of counterfeiting that threatens many lives per year worldwide, technologies such as our botanical DNA marking can play a key role, and Bob is well placed to strengthen our sales efforts and strategic relationships in this area." About Applied DNA Sciences
We make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. Our patented DNA-based solutions can be used to identify, tag, track, and trace products, to help assure authenticity, traceability and quality of products. SigNature® DNA describes the platform ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. We are also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.Go to adnas.com for more information, events and to learn more about how Applied DNA Sciences makes life real and safe. Common stock listed on NASDAQ under the symbol APDN, and warrants are listed under the symbol APDNW.  Forward-Looking Statements
The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 14, 2015,and our subsequent quarterly report on Form 10-Q filed on February 10, 2016 which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.
Investor contact:
Debbie Bailey
631-240-8817
[email protected]

Media contact:
Susan Forman
Dian Griesel Int'l.
212-825-3210
[email protected]

web: www.adnas.com
twitter: @APDN



Read more...
Applied DNA Sciences Schedules Fiscal 2016 Second Quarter Financial Results Conference Call and Webcast for May 12, 2016 at 4:30 pm ET
STONY BROOK, NY--(Marketwired - April 28, 2016) - Applied DNA Sciences (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based supply-chain, anti-counterfeiting and anti-theft technology, product genotyping and product authentication solutions, will host an investor call and simultaneous webcast on Thursday, May12, 2016 at 4:30 PM ET to discuss its fiscal 2016 second quarter financial results. Dr. James Hayward, President and CEO, and Beth Jantzen, CFO, of Applied DNA Sciences, plan to discuss the company's performance and achievements for the quarter and outline key ongoing business initiatives for the balance of the 2016 fiscal year. Management's commentary will be followed by a question-and-answer session. The investor call and webcast will be accompanied by a PowerPoint presentation, which will be made available on the Company's website at the start of the call.All participants to the conference call must pre-register using the link below. Due to the large number of expected participants, not all questions may be answered on the call. For those investors unable to attend the live call, call replay and webcast information is provided below. To Participate:
Reserve your conference call seat now at: http://dpregister.com/10084950. Conference call dial-in information will be provided at completion of the registration process.Live webcast: http://services.choruscall.com/links/apdn160512 Replay (available 1 hour following the conclusion of the live call):

Participant Toll Free: 1-877-344-7529 Participant Toll: 1-412-317-0088 Participant Passcode: 10084950 Webcast replay: http://services.choruscall.com/links/apdn160512 About Applied DNA Sciences
We make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. Our patented DNA-based solutions can be used to identify, tag, track, and trace products, to help assure authenticity, traceability and quality of products. SigNature® DNA describes the platform ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. We are also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.Go to adnas.com for more information, events and to learn more about how Applied DNA Sciences makes life real and safe. Common stock listed on NASDAQ under the symbol APDN, and warrants are listed under the symbol APDNW. Forward Looking Statements
The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 14, 2015, and our subsequent quarterly report on Form 10-Q filed on February 10, 2016 which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.
Investor contacts:
Debbie Bailey
631-240-8817
[email protected]

Sanjay M. Hurry
212-838-3777
[email protected]

Media contact:
Susan Forman
Dian Griesel Int'l.
212-825-3210
[email protected]

web: www.adnas.com
twitter: @APDN



Read more...

Ratios

vs
industry
vs
history
PB Ratio 3.80
APDN's PB Ratio is ranked lower than
76% of the 257 Companies
in the Global Security & Protection Services industry.

( Industry Median: 1.69 vs. APDN: 3.80 )
Ranked among companies with meaningful PB Ratio only.
APDN' s PB Ratio Range Over the Past 10 Years
Min: 3.35  Med: 16.7 Max: 337.39
Current: 3.8
3.35
337.39
PS Ratio 11.21
APDN's PS Ratio is ranked lower than
93% of the 250 Companies
in the Global Security & Protection Services industry.

( Industry Median: 1.24 vs. APDN: 11.21 )
Ranked among companies with meaningful PS Ratio only.
APDN' s PS Ratio Range Over the Past 10 Years
Min: 5.58  Med: 30.56 Max: 2700
Current: 11.21
5.58
2700
EV-to-EBIT -2.79
APDN's EV-to-EBIT is ranked lower than
99.99% of the 255 Companies
in the Global Security & Protection Services industry.

( Industry Median: 15.52 vs. APDN: -2.79 )
Ranked among companies with meaningful EV-to-EBIT only.
APDN' s EV-to-EBIT Range Over the Past 10 Years
Min: -34.7  Med: -3.8 Max: 9.4
Current: -2.79
-34.7
9.4
EV-to-EBITDA -2.93
APDN's EV-to-EBITDA is ranked lower than
99.99% of the 274 Companies
in the Global Security & Protection Services industry.

( Industry Median: 9.54 vs. APDN: -2.93 )
Ranked among companies with meaningful EV-to-EBITDA only.
APDN' s EV-to-EBITDA Range Over the Past 10 Years
Min: -23.5  Med: -4 Max: 17.3
Current: -2.93
-23.5
17.3
Current Ratio 3.33
APDN's Current Ratio is ranked higher than
80% of the 254 Companies
in the Global Security & Protection Services industry.

( Industry Median: 1.71 vs. APDN: 3.33 )
Ranked among companies with meaningful Current Ratio only.
APDN' s Current Ratio Range Over the Past 10 Years
Min: 0.01  Med: 0.29 Max: 8.02
Current: 3.33
0.01
8.02
Quick Ratio 3.25
APDN's Quick Ratio is ranked higher than
86% of the 253 Companies
in the Global Security & Protection Services industry.

( Industry Median: 1.40 vs. APDN: 3.25 )
Ranked among companies with meaningful Quick Ratio only.
APDN' s Quick Ratio Range Over the Past 10 Years
Min: 0.01  Med: 0.29 Max: 8.02
Current: 3.25
0.01
8.02
Days Inventory 65.16
APDN's Days Inventory is ranked lower than
51% of the 219 Companies
in the Global Security & Protection Services industry.

( Industry Median: 64.86 vs. APDN: 65.16 )
Ranked among companies with meaningful Days Inventory only.
APDN' s Days Inventory Range Over the Past 10 Years
Min: 65.16  Med: 72.8 Max: 72.8
Current: 65.16
65.16
72.8
Days Sales Outstanding 596.80
APDN's Days Sales Outstanding is ranked lower than
98% of the 203 Companies
in the Global Security & Protection Services industry.

( Industry Median: 64.60 vs. APDN: 596.80 )
Ranked among companies with meaningful Days Sales Outstanding only.
APDN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 31.36  Med: 78.73 Max: 596.8
Current: 596.8
31.36
596.8
Days Payable 722.16
APDN's Days Payable is ranked higher than
99% of the 172 Companies
in the Global Security & Protection Services industry.

( Industry Median: 50.39 vs. APDN: 722.16 )
Ranked among companies with meaningful Days Payable only.
APDN' s Days Payable Range Over the Past 10 Years
Min: 722.16  Med: 1176.74 Max: 19583.04
Current: 722.16
722.16
19583.04

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -22.50
APDN's 3-Year Average Share Buyback Ratio is ranked lower than
87% of the 146 Companies
in the Global Security & Protection Services industry.

( Industry Median: -1.20 vs. APDN: -22.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
APDN' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -484.8  Med: -32.2 Max: 12.6
Current: -22.5
-484.8
12.6

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 21.88
APDN's Price-to-Net-Cash is ranked lower than
81% of the 43 Companies
in the Global Security & Protection Services industry.

( Industry Median: 9.03 vs. APDN: 21.88 )
Ranked among companies with meaningful Price-to-Net-Cash only.
APDN' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 7.38  Med: 27 Max: 1524
Current: 21.88
7.38
1524
Price-to-Net-Current-Asset-Value 5.30
APDN's Price-to-Net-Current-Asset-Value is ranked lower than
58% of the 113 Companies
in the Global Security & Protection Services industry.

( Industry Median: 4.00 vs. APDN: 5.30 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
APDN' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 5  Med: 20.71 Max: 304.8
Current: 5.3
5
304.8
Price-to-Tangible-Book 4.38
APDN's Price-to-Tangible-Book is ranked lower than
72% of the 236 Companies
in the Global Security & Protection Services industry.

( Industry Median: 1.90 vs. APDN: 4.38 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
APDN' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 4.13  Med: 16.8 Max: 217.71
Current: 4.38
4.13
217.71
Price-to-Median-PS-Value 0.37
APDN's Price-to-Median-PS-Value is ranked higher than
95% of the 212 Companies
in the Global Security & Protection Services industry.

( Industry Median: 1.09 vs. APDN: 0.37 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
APDN' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.23  Med: 0.89 Max: 66.67
Current: 0.37
0.23
66.67
Earnings Yield (Greenblatt) % -35.82
APDN's Earnings Yield (Greenblatt) % is ranked lower than
96% of the 320 Companies
in the Global Security & Protection Services industry.

( Industry Median: 4.86 vs. APDN: -35.82 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
APDN' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -38.58  Med: 17.8 Max: 39.2
Current: -35.82
-38.58
39.2

More Statistics

Revenue (TTM) (Mil) $3.77
EPS (TTM) $ -0.54
Beta-2.03
Short Percentage of Float3.49%
52-Week Range $1.40 - 3.61
Shares Outstanding (Mil)26.35

Analyst Estimate

Sep17 Sep18
Revenue (Mil $) 15 20
EPS ($) -0.13 0.05
EPS without NRI ($) -0.13 0.05
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for APDN

Headlines

Articles On GuruFocus.com
Applied DNA Sciences Partners With Palmetto Synthetics and Techmer PM, Entering Synthetic Fibers for Jun 07 2016 
Applied DNA Sciences Appoints Dr. Barbara Brockway as Director of Personal Care Jun 06 2016 
Applied DNA Sciences Partners With CGPR May 25 2016 
Applied DNA Sciences to Present at Upcoming Mauldin Economics Strategic Investment Conference May 24 2016 
Applied DNA Sciences Signs Five-Year, $2.5 Million Blanket Purchase Agreement With Federal Agency May 10 2016 
Applied DNA Sciences Appoints Bob Miglani as Chief of Business Development May 05 2016 
Applied DNA Sciences Schedules Fiscal 2016 Second Quarter Financial Results Conference Call and Webc Apr 28 2016 
Applied DNA Sciences Launches Enhanced DNA Authentication Quantifying Cotton Species Apr 05 2016 

More From Other Websites
Applied DNA Sciences Schedules Fiscal 2017 Second Quarter Financial Results Conference Call and... Apr 27 2017
ETFs with exposure to Applied DNA Sciences, Inc. : April 26, 2017 Apr 26 2017
Applied DNA Sciences Signs 5-Year Supply Agreement for Bulk DNA Manufacturing Apr 20 2017
Applied DNA Sciences, BLC Leather Technology Centre Ltd Announce Sponsorship by Five Global Brands... Mar 29 2017
Applied DNA Sciences, Loftex to Debut "Innovate with CertainT", First Towels with Verified Recycled... Mar 24 2017
New CertainT(TM) Supply Chain Platform Certifies Authenticity and Origin of Products and Brands Mar 22 2017
Applied DNA Sciences, Inc. :APDN-US: Earnings Analysis: Q1, 2017 By the Numbers : March 20, 2017 Mar 20 2017
Applied DNA Sciences, Inc. to Present at The MicroCap Conference on April 4th in New York City at... Mar 16 2017
Applied DNA Sciences to Webcast Annual Meeting of Stockholders On March 8, 2017 Mar 03 2017
Applied DNA Sciences, Inc.: Consumers Value Authenticated Aloe Mar 03 2017
Identifying Uzbek Cotton Biomarkers: A Proposed Collaborative Framework to Eliminate Forced Labor Feb 27 2017
Applied DNA Sciences Expands Patent Portfolio with a Range of Advancements that Enable Company's... Feb 21 2017
BMW Dealers in Sweden Expand DNA Asset Marking Program Feb 16 2017
Applied DNA Sciences Builds Recurring Revenue in Synthetic Fiber Market with Third Purchase Order Feb 14 2017
APDN: An DNA solution for product authentication Feb 13 2017
Applied DNA Sciences reports 1Q loss Feb 09 2017
Applied DNA Sciences Reports Fiscal First Quarter 2017 Financial Results Feb 09 2017
Applied DNA Sciences Appoints Former NYPD Commissioner Ray Kelly to Strategic Advisory Board Jan 24 2017
Applied DNA Sciences Schedules Fiscal 2017 First Quarter Financial Results Conference Call and... Jan 23 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)